Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Bipolar drug nears approval

  • Comment
A schizophrenia drug could soon also be indicated for moderate to severe manic episodes of bipolar disorder.

The European Medicines Agency (EMEA) has issued a positive opinion on a Marketing Authorisation Application for aripiprazole in treating patients who experience predominantly manic episodes and whose manic episodes respond to the drug. Its developers expect a final decision on the marketing authorisation in April 2008.

Aripiprazole received approval for the treatment of schizophrenia in 2004. If approved, aripiprazole will be only the second atypical antipsychotic indicated for the prevention and treatment of manic episodes in the past five years.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs